
	Ms. Cheryl L. King has been the Chief Financial Officer of Payformance Corporation since November 12, 2013. Ms. King serves as the Chief Financial Officer of prIME Oncology, Inc. Ms. King was Partner of Tatum CFO Partners, LLP and Tatum, LLC. in the Atlanta office. Ms. King has 25 years of financial management experience with an emphasis on large, multi-national corporations across a broad range of industries. Ms. King experience working with companies in the financial services markets has provided her with extensive expertise in mergers and acquisitions, raising debt and equity capital, SEC reporting, contract negotiations, and strategic planning. Ms. King joined Tatum in October 1999 and served as Chief Financial Officer of Alogent Corporation. Ms. King served as Senior Vice-President and Chief Financial Officer of the card processing division of First Data Corporation. Ms. King also established operating and financial systems for establishment of a UK office. Ms. King served as Vice-President and Corporate Controller of First Data. Ms. King directed the financial process for the $1 billion initial public offering upon First Data&#39;s spin-off from American Express Company and subsequent secondary offering. Ms. King has been the Chairperson and board member of Women in Technology since 2010. She is a member of the board of directors of Technology Executives Roundtable. First Data honored Ms. King with a Pinnacle Award, the highest company award. Ms. King background includes seven years of public accounting experience with Ernst &amp; Young and Deloitte &amp; Touche. She advised clients on mergers and acquisitions, restructurings and divestitures. She is a Certified Public Accountant and a member of the Georgia Society of CPA&#39;s and the American Institute of CPA&#39;s. Ms. King graduated, cum laude, from Georgetown University with a B.S. in Business Administration and a major in Accounting.
